HomeBusinessHealthcare Industry Stock NewsModerna (MRNA): No Longer A One Hit Wonder?
00:00
00:00
05:04
Moderna (MRNA): No Longer A One Hit Wonder?

Moderna (MRNA): No Longer A One Hit Wonder?

The Moderna (MRNA) stock price rose today after the flu vaccine showed promising results in a phase three trial. Is Moderna no longer a one hit wonder that was associated with Covid-19? The healthcare company expects to release 15 new products over the next 5 years. George Tsilis weighs in on possible upcoming booster shots.

Fast Market

13 Sep 2023

SHARE

ON AIR
10:00 pm
Trading 360
replay
6:00 am
Gamma On
REPLAY
6:30 am
Gamma On
REPLAY
7:00 am
Gamma On
REPLAY
7:30 am
Gamma On
REPLAY
8:30 am
Gamma On
REPLAY
9:00 am
Gamma On
REPLAY
9:30 am
Gamma On
REPLAY
10:00 am
Gamma On
REPLAY
11:00 am
Gamma On
REPLAY
12:00 pm
Gamma On
REPLAY
1:00 pm
Morning Movers
2:00 pm
Morning Trade Live
4:00 pm
Trading 360
5:00 pm
Fast Market
6:00 pm
Next Gen Investing
7:00 pm
The Watch List
8:00 pm
Market On Close
9:30 pm
Market Overtime
REPLAY
ON AIR
10:00 pm
Trading 360
REPLAY
11:00 pm
Fast Market
REPLAY
12:00 am
Next Gen Investing
REPLAY
1:00 am
Gamma On
REPLAY
2:00 am
Market Overtime
REPLAY
2:30 am
Market Overtime
REPLAY
3:00 am
Gamma On
REPLAY
education
4:00 am
Inside the Mind of a Trader
REPLAY
education
4:30 am
Inside the Mind of a Trader
REPLAY
education
5:00 am
Inside the Mind of a Trader
REPLAY
education
5:30 am
Your First Trade
REPLAY

Get the Market Minute

Daily insights for every investor